Eric J. Bergstralh

14.4k total citations · 3 hit papers
138 papers, 10.1k citations indexed

About

Eric J. Bergstralh is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Nephrology. According to data from OpenAlex, Eric J. Bergstralh has authored 138 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Pulmonary and Respiratory Medicine, 24 papers in Surgery and 23 papers in Nephrology. Recurrent topics in Eric J. Bergstralh's work include Prostate Cancer Diagnosis and Treatment (57 papers), Prostate Cancer Treatment and Research (56 papers) and Kidney Stones and Urolithiasis Treatments (30 papers). Eric J. Bergstralh is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (57 papers), Prostate Cancer Treatment and Research (56 papers) and Kidney Stones and Urolithiasis Treatments (30 papers). Eric J. Bergstralh collaborates with scholars based in United States, Canada and Belarus. Eric J. Bergstralh's co-authors include John C. Lieske, Andrew D. Rule, Laureano J. Rangel, Xujian Li, R. Jeffrey Karnes, Michael L. Blute, Amy E. Krambeck, Stephen A. Boorjian, L. Joseph Melton and Matthew T. Gettman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Eric J. Bergstralh

137 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long‐term Outcome in 2444 Consecutively Treated Patients

2002 546 citations Eric J. Bergstralh et al. profile →
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

2013 427 citations Eric J. Bergstralh, R. Jeffrey Karnes et al. PLoS ONE profile →
Imaging Classification of Autosomal Dominant Polycystic Kidney Disease

2014 407 citations María V. Irazabal, Laureano J. Rangel et al. Journal of the American Society of Nephrology profile →

Peers

Countries citing papers authored by Eric J. Bergstralh

Since Specialization

Citations

This map shows the geographic impact of Eric J. Bergstralh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Bergstralh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Bergstralh more than expected).

Fields of papers citing papers by Eric J. Bergstralh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric J. Bergstralh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Bergstralh. The network helps show where Eric J. Bergstralh may publish in the future.

Co-authorship network of co-authors of Eric J. Bergstralh

This figure shows the co-authorship network connecting the top 25 collaborators of Eric J. Bergstralh. A scholar is included among the top collaborators of Eric J. Bergstralh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric J. Bergstralh. Eric J. Bergstralh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers 2015 ·PLoS ONE ·Hemamalini Ketha, Ravinder J. Singh, Stefan K. Grebe, Eric J. Bergstralh, Andrew D. Rule, John C. Lieske, Rajiv Kumar	32
2	Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community 2015 ·Mayo Clinic Proceedings ·Prince Singh, Felicity Enders, Lisa E. Vaughan, Eric J. Bergstralh, John Knoedler, Amy E. Krambeck, John C. Lieske, Andrew D. Rule	102
3	Primary Gleason Grade 4 at the Positive Margin Is Associated with Metastasis and Death Among Patients with Gleason 7 Prostate Cancer Undergoing Radical Prostatectomy 2014 ·European Urology ·Boyd R. Viers, William R. Sukov, Matthew T. Gettman, Laureano J. Rangel, Eric J. Bergstralh, Igor Frank, Matthew K. Tollefson, R. Houston Thompson, Stephen A. Boorjian, R. Jeffrey Karnes	29
4	The ROKS Nomogram for Predicting a Second Symptomatic Stone Episode 2014 ·Journal of the American Society of Nephrology ·Andrew D. Rule, John C. Lieske, Xujian Li, L. Joseph Melton, Amy E. Krambeck, Eric J. Bergstralh	181
5	Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy 2014 ·Prostate Cancer and Prostatic Diseases ·Suzanne Stewart, John C. Cheville, Thomas J. Sebo, Igor Frank, Stephen A. Boorjian, R. Houston Thompson, Matthew T. Gettman, Matthew K. Tollefson, (unknown), Sarah P. Psutka, Eric J. Bergstralh, Laureano J. Rangel, R. Jeffrey Karnes	7
6	Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria 2014 ·Kidney International ·Xiaojing Tang, Eric J. Bergstralh, Ramila A. Mehta, Terri J. Vrtiska, Dawn S. Milliner, John C. Lieske	52
7	Quantification of Asymptomatic Kidney Stone Burden by Computed Tomography for Predicting Future Symptomatic Stone Events 2014 ·Urology ·(unknown), Terri J. Vrtiska, Amy E. Krambeck, Cynthia H. McCollough, (unknown), Eric J. Bergstralh, John C. Lieske, Andrew D. Rule	40
8	Correction: BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer 2013 ·PLoS ONE ·Hifzur R. Siddique, Aijaz Parray, Weixiong Zhong, R. Jeffery Karnes, Eric J. Bergstralh, Shahriar Koochekpour, Johng S. Rhim, Badrinath R. Konety, Mohammad Saleem	6
9	Effect of metformin on prostate cancer outcomes after radical prostatectomy 2013 ·Urologic Oncology Seminars and Original Investigations ·Dharam Kaushik, R. Jeffrey Karnes, Manuel S. Eisenberg, Laureano J. Rangel, Rachel E. Carlson, Eric J. Bergstralh	47
10	Controlled Metabolic Diet Reduces Calcium Oxalate Supersaturation but Not Oxalate Excretion After Bariatric Surgery 2012 ·Urology ·Ran Pang, Michael Linnes, Helen M. O’Connor, Xujian Li, Eric J. Bergstralh, John C. Lieske	20
11	Germline PKHD1 mutations are protective against colorectal cancer 2011 ·Human Genetics ·Christopher J. Ward, Yanhong Wu, Ruth Johnson, John R. Woollard, Eric J. Bergstralh, Mine Cicek, Jason L. Bakeberg, Sandro Rossetti, Christina M. Heyer, Gloria M. Petersen, Noralene M. Lindor, Stephen N. Thibodeau, Peter C. Harris, Vicente E. Torres, Marie C. Hogan, Lisa A. Boardman	22
12	Long‐term survival after radical prostatectomy versus external‐beam radiotherapy for patients with high‐risk prostate cancer 2011 ·Cancer ·Stephen A. Boorjian, R. Jeffrey Karnes, Rosalia Viterbo, Laureano J. Rangel, Eric J. Bergstralh, Eric M. Horwitz, Michael L. Blute, Mark K. Buyyounouski	191
13	Determination of Serum and Plasma Sclerostin Concentrations by Enzyme-Linked Immunoassays 2011 ·The Journal of Clinical Endocrinology & Metabolism ·Melissa S. McNulty, Ravinder J. Singh, Xujian Li, Eric J. Bergstralh, Rajiv Kumar	57
14	Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease 2010 ·Journal of the American Society of Nephrology ·Marie C. Hogan, Tatyana V. Masyuk, (unknown), Vickie Kubly, Eric J. Bergstralh, Xujian Li, Bohyun Kim, Bernard F. King, James F. Glockner, David R. Holmes, Sandro Rossetti, Peter C. Harris, Nicholas F. LaRusso, Vicente E. Torres	237
15	Rituximab Therapy in Idiopathic Membranous Nephropathy 2010 ·Clinical Journal of the American Society of Nephrology ·Fernando C. Fervenza, Roshini S. Abraham, Stephen B. Erickson, María V. Irazabal, Alfonso Eirin, Ulrich Specks, Patrick H. Nachman, Eric J. Bergstralh, Nelson Leung, Fernando G. Cosio, Marie C. Hogan, John Dillon, LaTonya J. Hickson, Xujian Li, Daniel Cattran	207
16	Response to ‘Rituximab in membranous nephropathy’ 2008 ·Kidney International ·Fernando C. Fervenza, Fernando G. Cosio, Stephen B. Erickson, Ulrich Specks, Andrew M. Herzenberg, John Dillon, Nelson Leung, Irvin M. Cohen, Daniel N. Wochos, Eric J. Bergstralh, Michelle Hladunewich, Daniel Cattran	1
17	Impact of prostate‐specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8–10 cancers 2007 ·British Journal of Urology ·Stephen A. Boorjian, R. Jeffrey Karnes, Laureano J. Rangel, Eric J. Bergstralh, Igor Frank, Michael L. Blute	24
18	Simple graphic method for estimation of prostate-specific antigen doubling time 2006 ·Urology ·Shomik Sengupta, Jeffrey M. Slezak, Michael L. Blute, Eric J. Bergstralh	8
19	Obesity and survival after radical prostatectomy: A 10‐year prospective cohort study 2006 ·Cancer ·Sameer Siddiqui, Brant A. Inman, Shomik Sengupta, Jeffrey M. Slezak, Eric J. Bergstralh, Bradley C. Leibovich, Horst Zincke, Michael L. Blute	98
20	Is Body Size a Biomarker for Optimizing Dosing of Omega-3 Polyunsaturated Fatty Acids in the Treatment of Patients with IgA Nephropathy? 2006 ·Clinical Journal of the American Society of Nephrology ·James V. Donadío, Eric J. Bergstralh, Douglas M. Bibus, Joseph P. Grande	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact